Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE]).
Carvelli J, Meziani F, Dellamonica J, Cordier PY, Allardet-Servent J, Fraisse M, Velly L, Barbar SD, Lehingue S, Guervilly C, Desgrouas M, Camou F, Piperoglou C, Vely F, Demaria O, Karakunnel J, Fares J, Batista L, Rotolo F, Viotti J, Boyer-Chammard A, Lacombe K, Le Dault E, Carles M, Schleinitz N, Vivier E; FOR COVID Elimination (FORCE) Study Group. Carvelli J, et al. Among authors: vely f. Crit Care Med. 2022 Dec 1;50(12):1788-1798. doi: 10.1097/CCM.0000000000005683. Epub 2022 Oct 10. Crit Care Med. 2022. PMID: 36218354 Free PMC article. Clinical Trial.
Human epicardial fat has a beige profile and contains higher type 2 innate lymphoid cells than subcutaneous fat.
Doukbi E, Ancel P, Dutour A, Soghomonian A, Ahmed S, Castejon V, Piperoglou C, Gariboldi V, Lenoir M, Lechevallier E, Gondran-Tellier B, Boissier R, Ebbo M, Vély F, Gaborit B. Doukbi E, et al. Among authors: vely f. Obesity (Silver Spring). 2024 May 15. doi: 10.1002/oby.24023. Online ahead of print. Obesity (Silver Spring). 2024. PMID: 38747118
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis.
Graille-Avy L, Boutiere C, Rigollet C, Perriguey M, Rico A, Demortiere S, Durozard P, Hilezian F, Vely F, Bertault-Peres P, Pelletier J, Maarouf A, Audoin B. Graille-Avy L, et al. Among authors: vely f. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200231. doi: 10.1212/NXI.0000000000200231. Epub 2024 Apr 16. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38626360 Free PMC article.
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?
Claverie R, Perriguey M, Rico A, Boutiere C, Demortiere S, Durozard P, Hilezian F, Dubrou C, Vely F, Pelletier J, Audoin B, Maarouf A. Claverie R, et al. Among authors: vely f. Neurol Neuroimmunol Neuroinflamm. 2023 Aug 21;10(5):e200152. doi: 10.1212/NXI.0000000000200152. Print 2023 Sep. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37604695 Free PMC article.
Clinical, biological, electrophysiological and therapeutic profile of patients with anti-MAG neuropathy according to MYD88L265P and CXCR4 mutations and underlying haemopathy.
Guérémy A, Boucraut J, Boudjarane J, Grapperon AM, Fortanier E, Farnault L, Gabert J, Vely F, Lacroix R, Kouton L, Attarian S, Delmont E. Guérémy A, et al. Among authors: vely f. J Neurol. 2024 Mar;271(3):1320-1330. doi: 10.1007/s00415-023-12068-4. Epub 2023 Nov 18. J Neurol. 2024. PMID: 37979093
[Anti-cytokine autoantibodies: Review of the literature].
Gaigne L, Piperoglou C, Banzet N, Ghellab L, Vély F, Schleinitz N, Ebbo M. Gaigne L, et al. Among authors: vely f. Rev Med Interne. 2022 Sep;43(9):528-536. doi: 10.1016/j.revmed.2022.06.006. Epub 2022 Jul 9. Rev Med Interne. 2022. PMID: 35820937 Free article. Review. French.
Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia.
Crinier A, Dumas PY, Escalière B, Piperoglou C, Gil L, Villacreces A, Vély F, Ivanovic Z, Milpied P, Narni-Mancinelli É, Vivier É. Crinier A, et al. Among authors: vely f. Cell Mol Immunol. 2021 Nov;18(11):2578-2580. doi: 10.1038/s41423-021-00771-z. Cell Mol Immunol. 2021. PMID: 34588630 Free PMC article. No abstract available.
Late-Onset Progressive Multifocal Leukoencephalopathy (PML) and Lymphoma in a 65-Year-Old Patient with XIAP Deficiency.
Seguier J, Briantais A, Ebbo M, Meunier B, Aurran T, Coze S, Kaphan E, De Sainte Marie B, Sbihi Z, Latour S, Cerf-Bensussan N, Picard C, Vély F, Barlogis V, Schleinitz N. Seguier J, et al. Among authors: vely f. J Clin Immunol. 2021 Nov;41(8):1975-1978. doi: 10.1007/s10875-021-01139-8. Epub 2021 Sep 27. J Clin Immunol. 2021. PMID: 34580798 No abstract available.
Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers.
Kessel C, Vollenberg R, Masjosthusmann K, Hinze C, Wittkowski H, Debaugnies F, Nagant C, Corazza F, Vély F, Kaplanski G, Girard-Guyonvarc'h C, Gabay C, Schmidt H, Foell D, Tepasse PR. Kessel C, et al. Among authors: vely f. Arthritis Rheumatol. 2021 Oct;73(10):1791-1799. doi: 10.1002/art.41763. Epub 2021 Sep 3. Arthritis Rheumatol. 2021. PMID: 33880885 Free PMC article.
87 results